One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1200/jco.2016.34.15_suppl.4107
Copy DOI
Export
Save
Share
Cite Journal: Journal of Clinical Oncology |  Publication Date: May 20, 2016 |
Affiliation: Nara Medical University, Chuo University, The University of Tokyo, Kindai University, Kitasato Institute Hospital, Kitasato University, Kanagawa Prefectural Hospital Organization, Teine Keijinkai Hospital, Yokohama City University, Yokohama City University Medical Center, Kumamoto University, Aichi Cancer Center, Kansai Medical University, Osaka National Hospital, Shikoku Cancer Center, Wakayama Medical University, Sapporo Kosei General Hospital, Osaka City General Hospital
4107Background: S-1 is an active agent for the treatment of pancreatic cancer. GEST study has previously shown the noninferiority of S-1 to gemcitabine in advanced pancreatic cancer. However, the s...
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
